The iconic rise of Viagra has consistently remained a example of pharmaceutical success, yet its future within the broader industry now raises questions about potential returns . Copycat versions are eroding patent protection , prompting concerns that supporting companies heavily reliant to Viagra's once-dominant standing could be a speculative mov